ARTICLES
Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues
YZ Patt
JCO May 1 1993: 815–819. [PDF]
Back to the basics: the importance of concentration x time in oncology
SD Weitman, E Glatstein, and BA Kamen
JCO May 1 1993: 820–821. [PDF]
	Regional chemotherapy devices: effect of experience and anatomy on complications
	KA Campbell, RC Burns, JV Sitzmann, PA Lipsett, LB Grochow, and JE Niederhuber
	JCO May 1 1993: 822–826. [Abstract] [PDF]
	Randomized comparison of 36-hour intermediate-dose versus 4-hour high- dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia
	C Wolfrom, R Hartmann, R Fengler, S Bruhmuller, A Ingwersen, and G Henze
	JCO May 1 1993: 827–833. [Abstract] [PDF]
	Unrelated-donor bone marrow transplantation for Philadelphia chromosome- positive chronic myelogenous leukemia in children
	AS Gamis, R Haake, P McGlave, and NK Ramsay
	JCO May 1 1993: 834–838. [Abstract] [PDF]
	Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study
	J Pullen, J Boyett, J Shuster, W Crist, V Land, L Frankel, R Iyer, L Backstrom, J van Eys, and M Harris
	JCO May 1 1993: 839–849. [Abstract] [PDF]
	Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood
	RJ Packer, B Lange, J Ater, HS Nicholson, J Allen, R Walker, M Prados, R Jakacki, G Reaman, and MN Needles
	JCO May 1 1993: 850–856. [Abstract] [PDF]
	Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02
	WJ Curran, Jr, CB Scott, AS Weinstein, LA Martin, JS Nelson, TL Phillips, K Murray, AJ Fischbach, D Yakar, and JG Schwade
	JCO May 1 1993: 857–862. [Abstract] [PDF]
	The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of- life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer
	GP Browman, MN Levine, DI Hodson, J Sathya, R Russell, P Skingley, C Cripps, L Eapen, and A Girard
	JCO May 1 1993: 863–872. [Abstract] [PDF]
	Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group
	DR Gandara, J Crowley, RB Livingston, EA Perez, CW Taylor, G Weiss, JR Neefe, LF Hutchins, RW Roach, and SM Grunberg
	JCO May 1 1993: 873–878. [Abstract] [PDF]
	Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group
	DH Johnson, AT Turrisi, AY Chang, R Blum, P Bonomi, D Ettinger, and H Wagner
	JCO May 1 1993: 879–884. [Abstract] [PDF]
	Successful re-treatment with taxol after major hypersensitivity reactions
	DM Peereboom, RC Donehower, EA Eisenhauer, WP McGuire, N Onetto, JL Hubbard, M Piccart, L Gianni, and EK Rowinsky
	JCO May 1 1993: 885–890. [Abstract] [PDF]
	Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60
	E Kimura, RE Enns, JE Alcaraz, J Arboleda, DJ Slamon, and SB Howell
	JCO May 1 1993: 891–898. [Abstract] [PDF]
	Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis
	JA Foekens, WL van Putten, H Portengen, HY de Koning, B Thirion, J Alexieva- Figusch, and JG Klijn
	JCO May 1 1993: 899–908. [Abstract] [PDF]
	Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group
	Y Shimada, M Yoshino, A Wakui, I Nakao, K Futatsuki, Y Sakata, M Kambe, T Taguchi, and N Ogawa
	JCO May 1 1993: 909–913. [Abstract] [PDF]
	Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenstrom's macroglobulinemia
	MA Gertz, RA Kyle, and P Noel
	JCO May 1 1993: 914–920. [Abstract] [PDF]
	Interleukin-2-induced thyroid dysfunction is correlated with treatment duration but not with tumor response
	WH Kruit, RL Bolhuis, SH Goey, RL Jansen, AM Eggermont, D Batchelor, PI Schmitz, and G Stoter
	JCO May 1 1993: 921–924. [Abstract] [PDF]
	Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease
	S Tura, M Fiacchini, PL Zinzani, E Brusamolino, and PG Gobbi
	JCO May 1 1993: 925–930. [Abstract] [PDF]
	Autologous bone marrow transplantation in poor-prognosis intermediate- grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study
	AS Freedman, T Takvorian, D Neuberg, P Mauch, SN Rabinowe, KC Anderson, RJ Soiffer, N Spector, M Grossbard, and MJ Robertson
	JCO May 1 1993: 931–936. [Abstract] [PDF]
	Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome
	LN Shulman, B Frisard, JH Antin, C Wheeler, G Pinkus, N Magauran, P Mauch, E Nobles, R Mashal, and G Canellos
	JCO May 1 1993: 937–942. [Abstract] [PDF]
	Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy
	TM Waits, FA Greco, JP Greer, DH Johnson, SN Wolff, RS Stein, ML McMaster, and JD Hainsworth
	JCO May 1 1993: 943–949. [Abstract] [PDF]
	Phase I clinical trial of taxotere administered as either a 2-hour or 6- hour intravenous infusion
	H Burris, R Irvin, J Kuhn, S Kalter, L Smith, D Shaffer, S Fields, G Weiss, J Eckardt, and G Rodriguez
	JCO May 1 1993: 950–958. [Abstract] [PDF]
	Phase I evaluation of all-trans-retinoic acid in adults with solid tumors
	JS Lee, RA Newman, SM Lippman, MH Huber, T Minor, MN Raber, IH Krakoff, and WK Hong
	JCO May 1 1993: 959–966. [Abstract] [PDF]
	Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer
	JW Finn, TD Walsh, N MacDonald, E Bruera, LU Krebs, and KV Shepard
	JCO May 1 1993: 967–972. [Abstract] [PDF]
	Dose-ranging study of oxycodone for chronic pain in advanced cancer
	PA Glare and TD Walsh
	JCO May 1 1993: 973–978. [Abstract] [PDF]
	Psychosocial outcomes of cancer: a comparative analysis of Hodgkin's disease and testicular cancer
	JR Bloom, P Fobair, E Gritz, D Wellisch, D Spiegel, A Varghese, and R Hoppe
	JCO May 1 1993: 979–988. [Abstract] [PDF]
	Cancer by another name: a randomized trial of the effects of euphemism and uncertainty in communicating with cancer patients
	SM Dunn, PU Patterson, PN Butow, HH Smartt, WH McCarthy, and MH Tattersall
	JCO May 1 1993: 989–996. [Abstract] [PDF]
	Assessment of sleep in patients with lung cancer and breast cancer
	PM Silberfarb, PJ Hauri, TE Oxman, and P Schnurr
	JCO May 1 1993: 997–1004. [Abstract] [PDF]
Assessing secondary malignancy risk
JR Anderson and PK Roberson
JCO May 1 1993: 1005a. [PDF]
Relationship between tumor area, tumor volume, and criteria of response in clinical trials [published erratum appears in J Clin Oncol 1993 Sep;11(9):1839]
G Clamon and L Clamon
JCO May 1 1993: 1005b. [PDF]
A cry from the fringe
DE Weissman, J O'Donnell, and A Brady
JCO May 1 1993: 1006. [PDF]

SPECIAL DEPARTMENTS
ERRATUM
	Long-Term Reduction in Sperm Count After Chemotherapy With and Without Radiation Therapy for Non-Hodgkin's Lymphomas
	Rodger M. Pryzant, Marvin L. Meistrich, Gene Wilson, Barry Brown, and Peter McLaughlin
	JCO May 1 1993: 1007. [Abstract] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.